Dabigatran deliberate overdose: two cases and suggestions for laboratory monitoring.

about

Management of Dabigatran-Associated Bleeding with Two Doses of Idarucizumab Plus Hemodialysis.

P2860

Q48375140-8D216B45-D811-4A0A-BAA1-8EED8CF749C8

P2860

Dabigatran deliberate overdose: two cases and suggestions for laboratory monitoring.

Item

http://www.wikidata.org/entity/Q48889301

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Dabigatran deliberate overdose: two cases and suggestions for laboratory monitoring.

@en

Dabigatran deliberate overdose: two cases and suggestions for laboratory monitoring.

@nl

type

Item

label

Dabigatran deliberate overdose: two cases and suggestions for laboratory monitoring.

@en

Dabigatran deliberate overdose: two cases and suggestions for laboratory monitoring.

@nl

prefLabel

Dabigatran deliberate overdose: two cases and suggestions for laboratory monitoring.

@en

Dabigatran deliberate overdose: two cases and suggestions for laboratory monitoring.

@nl

P1476

Dabigatran deliberate overdose: two cases and suggestions for laboratory monitoring.

@en

P2093

Ioana Vlad

http://www.w3.org/2001/XMLSchema#string

James Ridgley

http://www.w3.org/2001/XMLSchema#string

Jason Armstrong

http://www.w3.org/2001/XMLSchema#string

Ovidiu Pascu

http://www.w3.org/2001/XMLSchema#string

P2860

Dabigatran versus warfarin in patients with atrial fibrillation

Idarucizumab for Dabigatran Reversal

Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity

Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: guidance from the British Committee for Standards in Haematology.

Dabigatran etexilate: a new oral thrombin inhibitor.

Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant.

Positive outcome after intentional overdose of dabigatran.

Pharmacobezoars described and demystified.

Removal of dabigatran by hemodialysis.

Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran.

P304

286-289

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/15563650.2015.1126287

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26735702

http://www.w3.org/2001/XMLSchema#string

P921

drug overdose

Dabigatran deliberate overdose: two cases and suggestions for laboratory monitoring.

about

P2860

P2860

Dabigatran deliberate overdose: two cases and suggestions for laboratory monitoring.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921